Unmet treatment needs of gastroesophageal reflux disease in Asia: Gastroesophageal reflux disease in Asia Pacific Survey-Reference-Cited by-同舟云学术

Unmet treatment needs of gastroesophageal reflux disease in Asia: Gastroesophageal reflux disease in Asia Pacific Survey

Published:2014-11-18 Issue:12 Volume:29 Page:1969-1975
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:J Gastroenterol Hepatol

Author:

Goh Khean Lee¹,Choi Myung Gyu²,Hsu William Ping I³,Chun Hoon Jai⁴,Mahachai Varocha⁵,Kachintorn Udom⁶,Leelakusolvong Somchai⁶,Kim Nayoung⁷,Rani Abdul Aziz⁸,Wong Benjamin CY⁹,Wu Justin¹⁰,Chiu Cheng Tang¹¹,Chu Romeo¹²,Shetty Vikram¹²,Bocobo Joseph C¹³^ORCID,Chan Melchor M¹⁴,Lin Jaw Town¹⁵

Affiliation:

1. Department of Medicine; University of Malaya; Kuala Lumpur Malaysia

2. Department of Internal Medicine; Catholic University of Korea

3. Department of Internal Medicine; Kaohsiung Veterans General Hospital; Kaohsiung Taiwan

4. Department of Internal Medicine; Korea University College of Medicine; Seoul Republic of Korea

5. Division of Gastroenterology; Chulalongkorn University

6. Division of Gastroenterology; Department of Internal Medicine; Siriraj Hospital; Mahidol University; Bangkok Thailand

7. Department of Internal Medicine; Seoul National University Bundang Hospital; Seongnam Republic of Korea

8. Department of Internal Medicine; University of Indonesia; Depok Indonesia

9. Department of Medicine; The University of Hong Kong

10. Department of Medicine and Therapeutics; The Chinese University of Hong Kong; Hong Kong SAR China

11. Department of Gastroenterology and Hepatology; Chang Gung Memorial Hospital; Taoyuan Taiwan

12. Medical Affairs; Takeda Pharmaceuticals (Asia Pacific) Pte Ltd; Singapore

13. St. Luke's College of Medicine-William H. Quasha Memorial; Quezon City

14. Faculty of Medicine and Surgery; University of Santo Tomas Hospital; Manila Philippines

15. Department of Medicine; Fu Jen Catholic University; New Taipei City Taiwan

Funder

Takeda Pharmaceuticals (Asia Pacific) Pte Ltd

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgh.12655/fullpdf

Reference18 articles.

1. Asia-Pacific consensus on the management of gastroesophageal reflux disease: update;Fock;J. Gastroenterol. Hepatol.,2008

2. The impact of nocturnal symptoms associated with gastroesophageal reflux disease on health-related quality of life;Farup;Arch. Intern. Med.,2001

3. Nighttime heartburn is an under-appreciated clinical problem that impacts sleep and daytime function: the results of a Gallup survey conducted on behalf of the American Gastroenterological Association;Shaker;Am. J. Gastroenterol.,2003

4. American Gastroenterological Society 2011 New nationwide survey identifies need for increased dialogue between gastroesophageal reflux disease or frequent heartburn sufferers and health care providers www.gastro.org/news/articles/2011/03/23/new-nationwide-survey-identifies-need-for-increased-dialogue-between-gastroesophageal-reflux-disease-or-frequent-heartburn-sufferers-and-health-care-providers

5. Gastroesophageal reflux disease in Asia: a historical perspective and present challenges;Goh;J. Gastroenterol. Hepatol.,2011

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of self-reported and objective sleep disturbance with the spectrum of gastroesophageal reflux disease;Journal of Clinical Sleep Medicine;2024-06

2. Symptom Profile, Proton Pump Inhibitor Therapy, and Diagnostic Testing in Patients With Persistent Reflux-Like Symptoms: Results From a Population-Based Survey;Foregut: The Journal of the American Foregut Society;2023-05-27

3. Proton Pump Inhibitors and Cancer Risk;American Journal of Clinical Oncology;2022-10-18

4. Randomized clinical trial: A double‐blind, proof‐of‐concept, phase 2 study evaluating the efficacy and safety of vonoprazan 20 or 40 mg versus esomeprazole 40 mg in patients with symptomatic gastro‐esophageal reflux disease and partial response to a healing dose of a proton‐pump inhibitor;Neurogastroenterology & Motility;2022-09-30

5. Thailand guideline 2020 for medical management of gastroesophageal reflux disease;Journal of Gastroenterology and Hepatology;2022-01-25